Advertisement

Topics

Orexigen Therapeutics, Inc. Company Profile

05:30 EST 10th December 2018 | BioPortfolio

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Further information about the Company can be found at www.orexigen.com.


News Articles [698 Associated News Articles listed on BioPortfolio]

Pernix Therapeutics Buys Bankrupt Orexigen’s Weight Loss Drug for $73.5 Million

In March, San Diego-based Orexigen Therapeutics filed for bankruptcy. Back in April, Orexigen entered into an asset purchase deal with Nalpropion Pharmaceuticals to sell most of its assets, subject to...

Pernix-Backed Biz Picks Up Orexigen’s Weight Loss Drug for $74M

Orexigen Therapeutics went bankrupt trying to turn its weight loss pill, Contrave, into a commercial success. Now Pernix Therapeutics will try its luck. Pernix (NASDAQ: PTX) said Monday that a busines...

Pernix Wins Auction; Orexigen's Sale Of Contrave Looks To Be Complete

Orexigen Blunder, PTV News: Apr 14, 2010

Biotech’s shares slide after it admits obesity drug data contained mistakes

News Headlines, PTV News: Apr 14, 2010

A look at today's forthcoming stories: Research highlights suicide risks of widely prescribed anticonvulsants; BioTrinity 2010 - the UK’s premier Biopartnering and Investment conference, and the cle...

Orexigen Therapeutics Inc OREX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryOrexigen Therapeutics Inc Orexigen is a biopharmaceutical company which develops and commercializes indications for the treatment of obesity. Its lead product, Contrave naltrexone HCl / bupropi...

Which drug targets will drive the obesity market for the next decade?

Novo Nordisk’s glucagon-like peptide-1 receptor agonist (GLP-1RA), Saxenda (liraglutide), and Pernix’s (formerly Orexigen’s) Contrave designed to reduce food intake, dominated...Read More... The...

M&As this week: Nabriva Therapeutics, Sangamo Therapeutics, Ryboquin

Nabriva Therapeutics has completed the acquisition of Zavante Therapeutics for $97.5m. The acquisition will add the target company’s CONTEPO™ drug, which...Read More... The post M&As this we...

PubMed Articles [457 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development.

Clinical Trials [164 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1284 Associated Companies listed on BioPortfolio]

Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Further information about the Company can be found at www.orexigen.com.

Blue Chip Marketing Worldwide

Blue Chip Marketing Worldwide (www.bluechipmarketingworldwide.com), this year celebrating its 30th anniversary, is an independent, full-service global marketing agency that delive...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Orexigen Therapeutics, Inc." on BioPortfolio

We have published hundreds of Orexigen Therapeutics, Inc. news stories on BioPortfolio along with dozens of Orexigen Therapeutics, Inc. Clinical Trials and PubMed Articles about Orexigen Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orexigen Therapeutics, Inc. Companies in our database. You can also find out about relevant Orexigen Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record